PR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PR, covering 2021-03-23 to 2021-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III [Phase 3]